-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Cellectar Biosciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
- Cellectar Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $12.8M.
- Cellectar Biosciences, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$5.36M, a 4.83% decline year-over-year.
- Cellectar Biosciences, Inc. annual Nonoperating Income (Expense) for 2023 was -$3.87M, a 27.4% decline from 2022.
- Cellectar Biosciences, Inc. annual Nonoperating Income (Expense) for 2022 was -$3.04M, a 34175% decline from 2021.
- Cellectar Biosciences, Inc. annual Nonoperating Income (Expense) for 2021 was $8.92K, a 95.5% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)